Medela simplifies the delivery and management of Negative Pressure Wound Therapy (NPWT)

Published on:

MCHENRY, IL. May 30, 2017 – Medela Healthcare announces the launch of the new Invia® FitPad™ Negative Pressure Wound Therapy dressing portfolio, making NPWT easier for healthcare professionals and patients. “With the launch of this versatile portfolio of devices and dressings, Medela’s new NPWT portfolio supports easier patient transitions from hospital to home. Our NPWT solutions are designed for ease-of-use by clinicians and patients”, states Dan Hyun, Vice President Medela Healthcare US.

NPWT from Medela helps reduce the clinical and administrative complexity of therapy. Medela`s Invia® Liberty™ and Invia® Motion™ systems include a new dynamic pressure management feature which helps ensure controlled and reliable negative pressure delivery at the wound site[1]. The new FitPad suction interface enables the dynamic measurement of pressure settings from the pump to the dressing site.

Medela provides a streamlined portfolio of both foam and gauze dressings. Invia Dressing Kits are available in a full range of sizes. All FitPad kits share the same adhesive transparent film, a low-profile FitPad suction interface and a Quick-connector for secure and convenient[2] tubing attachment. Medela NPWT Patients and their Caregivers can now have confidence in their therapy from pump to wound site.

The Invia® Motion™ completes the Medela portfolio, combining the convenience of a personal use system with the performance associated with a reusable pump. Invia Motion can be used in all patient care settings and assists with patient transitions throughout the continuum of care.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Radiology Business
Society of Interventional Radiology seeks AMA resolution urging payments on high-cost disposables

"The number of non-facility services reimbursed at less than direct costs grew 50% since 2024. The number of services under the MPFS for which reimbursement does not even cover cost likely is much higher than 300 services," the proposed AMA resolution states.

Cardiovascular Business
FDA wants new heart damage warnings added to COVID-19 vaccines

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

Cardiovascular Business
Cardiology employment models undergoing a dramatic shift

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.